Published in Hepatitis Weekly, March 15th, 2010
"Diplomat's specialty patients average better than 90% adherence to their medications, while the national average is 50-70% for chronic medicines. Still, we can't address the adherence issue with these patients when they don't have the drug to begin with," says Diplomat Specialty Pharmacy President and CEO Phil Hagerman, RPh.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.